← Back to Search

Procedure

Tetragraph for Neuromuscular Blockade

N/A
Waitlist Available
Led By J.Ross Renew, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 hour postoperatively
Awards & highlights

Study Summary

This trial is comparing two ways of measuring how well a patient's muscles respond to nerve stimulation during surgery.

Eligible Conditions
  • Residual Neuromuscular Blockade

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 hour postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 hour postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of Values Between Tetragraph and ToFscan
Secondary outcome measures
Incidence of Residual Neuromuscular Blockade

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non-dominant handExperimental Treatment2 Interventions
Subject scheduled to undergo an elective surgical procedure will have TetraGraph device lead placement on the non-dominant hand, ToFscan placed on dominant hand
Group II: Dominant handExperimental Treatment2 Interventions
Subject scheduled to undergo an elective surgical procedure will have TetraGraph device lead placement on the dominant hand, ToFscan placed on non-dominant hand
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ToFscan
2020
N/A
~60
Tetragraph
2020
N/A
~60

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,209 Previous Clinical Trials
3,767,074 Total Patients Enrolled
2 Trials studying Neuromuscular Blockade
145 Patients Enrolled for Neuromuscular Blockade
J.Ross Renew, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
186 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently accepting new participants?

"The information on clinicaltrials.gov suggests that this particular trial is not currently open for enrolment, having been initially published on August 18th 2020 with the last update being made January 5th 2022. However, there are still five other studies actively seeking participants at present."

Answered by AI
~13 spots leftby Apr 2025